Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biofrontera (BFRI) Income from Continuing Operations: 2020-2025

Historic Income from Continuing Operations for Biofrontera (BFRI) over the last 5 years, with Sep 2025 value amounting to -$6.6 million.

  • Biofrontera's Income from Continuing Operations fell 17.29% to -$6.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$17.6 million, marking a year-over-year decrease of 36.89%. This contributed to the annual value of -$17.8 million for FY2024, which is 11.78% up from last year.
  • According to the latest figures from Q3 2025, Biofrontera's Income from Continuing Operations is -$6.6 million, which was down 24.89% from -$5.3 million recorded in Q2 2025.
  • Biofrontera's Income from Continuing Operations' 5-year high stood at $5.6 million during Q1 2022, with a 5-year trough of -$16.0 million in Q3 2021.
  • Over the past 3 years, Biofrontera's median Income from Continuing Operations value was -$5.7 million (recorded in 2024), while the average stood at -$4.9 million.
  • In the last 5 years, Biofrontera's Income from Continuing Operations skyrocketed by 257.36% in 2022 and then tumbled by 1,971.60% in 2025.
  • Biofrontera's Income from Continuing Operations (Quarterly) stood at -$14.5 million in 2021, then skyrocketed by 80.80% to -$2.8 million in 2022, then spiked by 226.61% to $3.5 million in 2023, then slumped by 139.59% to -$1.4 million in 2024, then decreased by 17.29% to -$6.6 million in 2025.
  • Its Income from Continuing Operations was -$6.6 million in Q3 2025, compared to -$5.3 million in Q2 2025 and -$4.2 million in Q1 2025.